FDA Warns Pharmaceutical Industry to Test for DEG

The U.S. Food and Drug Administration has warned pharmaceutical manufacturers, suppliers, drug repackers and health professionals who compound medications to be especially vigilant in assuring that glycerin, a sweetener commonly used in liquid over-the-counter and prescription drug products, is not contaminated with diethylene glycol (DEG).

ROCKVILLE, Md. — The U.S. Food and Drug Administration has warned pharmaceutical manufacturers, suppliers, drug repackers and health professionals who compound medications to be especially vigilant in assuring that glycerin, a sweetener commonly used in liquid over-the-counter and prescription drug products, is not contaminated with diethylene glycol (DEG). The association said while it has no reason to believe that the U.S. supply of glycerin is contaminated with DEG, it is emphasizing

Register to view the full article